nach oben

Journal of Interventional Cardiac Electrophysiology

Erschienen in:

01.12.2007

Atrial fibrillation surgery for patients with rheumatic valve disease

verfasst von: Yosuke Ishii, Takashi Nitta

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Abstract

Atrial fibrillation (AF) is commonly associated with rheumatic valve disease. The dilated left atrium, degeneration of the left atrial myocardium, and elevated atrial pressure all contribute to perpetuation of AF. Over the past decade, the Maze procedure has evolved into the gold standard of treatment for medically refractory AF. The atrial incisions of the Maze procedure are designed to block potential macroreentrant pathways and propagation of microreentrant wavelets. The dilated left atrium and degeneration of the atrial myocardium caused by rheumatic inflammation participate in recurrence of postoperative AF years after surgery. Increased inflammatory response correlates with occurrence of postoperative AF. Pre- and postoperative anti-inflammatory therapy might be effective in decreasing the recurrence of AF in rheumatic heart disease patients. This article reviews the mechanisms of AF and surgical procedures in rheumatic valve disease.

Feinberg, W. B. J., Laupacis, A., Kronmal, R., & Hart, R. G. (1995). Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Archives of Internal Medicine, 155, 469–473.PubMedCrossRef

Brodell, G. K. C. D., Schiavone, W., Underwood, D. A., & Loop, F. D. (1991). Cardiac rhythm and conduction disturbances in patients undergoing mitral valve surgery. Cleveland Clinic Journal of Medicine, 58, 397–399.PubMed

Proclemer, A. D. B., Tondo, C., Facchin, D., Carbucicchio, C., Riva, S., Fioretti, P. (1999). Radiofrequency ablation of atrioventricular junction and pacemaker implantation versus modulation of atrioventricular conduction in drug refractory atrial fibrillation. American Journal of Cardiology, 83, 1437–1442.PubMedCrossRef

Kannel, W. B. W. P., Benjamin, E. J., & Levy, D. (1998). Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates. American Journal of Cardiology, 82, 2N–9N.PubMedCrossRef

Prystowsky, E. N. B. D., Fuster, V., Hart, R. G., Kay, G. N., Myerburg, R. J., Naccarelli, G. V., & Wyse, D. G. (1996). Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation, 93, 1262–1277.PubMed

Wolf, P. A. A. R., & Kannel, W. B. (1991). Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke, 22, 983–988.PubMed

Kristensson, B. E. A. K., & Ryden, L. (1985). The haemodynamic importance of atrioventricular synchrony and rate increase at rest and during exercise. European Heart Journal, 6, 773–778.PubMed

Cox, J. L., Schuessler, R. B., D’Agostino H. J. Jr., Stone, C. M., Chang, B. C., Cain, M. E., et al. (1991). The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. Journal of Thoracic and Cardiovascular Surgery, 101, 569–583.PubMed

Cox, J. L. B. J., Schuessler, R. B., Kater, K. M., & Lappas, D. G. (1993). Five-year experience with the maze procedure for atrial fibrillation. Annals of Thoracic Surgery, 56, 814–823.PubMedCrossRef

10.

Cox, J. L. B. J., Schuessler, R. B., Jaquiss, R. D., & Lappas, D. G. (1995). Modification of the maze procedure for atrial flutter and atrial fibrillation. I. Rationale and surgical results. Journal of Thoracic and Cardiovascular Surgery, 110, 473–484.PubMedCrossRef

11.

Cox, J. L., Schuessler, R. B., Lappas, D. G. & Boineau, J. P. (1996). An 8 1/2-year clinical experience with surgery for atrial fibrillation. Annals of Surgery, 224, 267–273.PubMedCrossRef

12.

Fukada, J. M. K., Komatsu, K., Sato, H., Shiiku, C., Muraki, S., Tsukamoto, M., et al. (1998). Is atrial fibrillation resulting from rheumatic mitral valve disease a proper indication for the maze procedure? Annals of Thoracic Surgery, 65, 1566–1569.PubMedCrossRef

13.

Lee, J. W. P. N., Choo, S. J., Jo, M. S., Song, H., & Song, M. G. (2003). Surgical outcome of the maze procedure for atrial fibrillation in mitral valve disease: Rheumatic versus degenerative. Annals of Thoracic Surgery, 75, 57–61.PubMedCrossRef

14.

Cox, J. L. (2003). Atrial fibrillation I: A new classification system. Journal of Thoracic and Cardiovascular Surgery, 126, 1686–1692.PubMedCrossRef

15.

Saito, T. T. K., Uchida, D., Saito, T., Togashi, M., Nitta, T., & Sugisaki, Y. (2007). Histopathological features of the resected left atrial appendage as predictors of recurrence after surgery for atrial fibrillation in valvular heart disease. Circulation Journal 1, 70–78

16.

Haissaguerre, M. J. P., Shah, D. C., Takahashi, A., Hocini, M., Quiniou, G., Garrigue, S., et al. (1998). Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. New England Journal of Medicine, 339, 659–666.PubMedCrossRef

17.

Oral, H. O. M., Tada, H., Chugh, A., Scharf, C., Hassan, S., Lai, S., et al. (2002). Mechanistic significance of intermittent pulmonary vein tachycardia in patients with atrial fibrillation. Journal of Cardiovascular Electrophysiology, 13, 645–650.PubMedCrossRef

18.

Jalife, J. (2003). Rotors and spiral waves in atrial fibrillation. Journal of Cardiovascular Electrophysiology, 14, 776–780.PubMedCrossRef

19.

Kim, K. B. C. K., Sohn, D. W., Ahn, H., & Rho, J. R. (1999). The Cox-Maze III procedure for atrial fibrillation associated with rheumatic mitral valve disease. Annals of Thoracic Surgery, 68, 799–803.PubMedCrossRef

20.

Guilherme, L. C.-N. E., Coelho, V., Snitcowsky, R., Pomerantzeff, P. M., Assis, R. V., Pedra, F., et al. (1995). Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation, 92, 415–420.PubMed

21.

Bailey, G. W. B. B., Hancock, E. W., & Cohn, K. E. (1968). Relation of left atrial pathology to atrial fibrillation in mitral valvular disease. Annals of Internal Medicine, 69, 13–20.PubMed

22.

Byrd, G. D., Prasad, S. M., Ripplinger, C. M., Cassilly, T. R., Schuessler, R. B., Boineau P., & Damiano, R. J., Jr. (2005). Importance of geometry and refractory period in sustaining atrial fibrillation: testing the critical mass hypothesis. Circulation, 112, I7–I13.PubMedCrossRef

23.

Bando, K. K. J., Kosakai, Y., Hirata, M., Sasako, Y., Nakatani, S., Yagihara, T., et al. (2002). Impact of Cox maze procedure on outcome in patients with atrial fibrillation and mitral valve disease. Journal of Thoracic and Cardiovascular Surgery, 124, 575–583.PubMedCrossRef

24.

Nakajima, H. K. J., Bando, K., Yasumura, Y., Nakatani, S., Kimura, K., Niwaya, K., et al. (2004). Consequence of atrial fibrillation and the risk of embolism after percutaneous mitral commissurotomy: The necessity of the maze procedure. Annals of Thoracic Surgery, 78, 800–805.PubMedCrossRef

25.

Prasad, S. M., Maniar, H. S., Camillo, C. J., Schuessler, R. B., Boineau, J. P., Sundt, T. M., et al. (2003). The Cox maze III procedure for atrial fibrillation: Long-term efficacy in patients undergoing lone versus concomitant procedures. Journal of Thoracic and Cardiovascular Surgery, 126, 1822–1827.PubMedCrossRef

26.

Petersen, P. B. G., Godtfredsen, J., Andersen, E. D., & Andersen, B. (1989). Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet, 1, 175–179.PubMedCrossRef

27.

Anonymous (1990). Preliminary report of the stroke prevention in atrial fibrillation study. New England Journal of Medicine, 322, 863–868.

28.

Cox, J. L. A. N., Palazzo, T., Fitzpatrick, S., Suyderhoud, J. P., DeGroot, K. W., Pirovic, E. A., et al. (2000). Current status of the Maze procedure for the treatment of atrial fibrillation. Seminars in Thoracic and Cardiovascular Surgery, 12, 15–19.PubMedCrossRef

29.

Guang, Y. Z.-J. C., Yong, L. W., Tong, L., & Ying, L. (2002). Evaluation of clinical treatment of atrial fibrillation associated with rheumatic mitral valve disease by radiofrequency ablation. European Journal of Cardio-thoracic Surgery, 21, 249–254.PubMedCrossRef

30.

Kosakai, Y. K. A., Isobe, F., Sasako, Y., Nakano, K., Eishi, K., Tanaka, N., et al. (1994). Cox maze procedure for chronic atrial fibrillation associated with mitral valve disease. Journal of Thoracic and Cardiovascular Surgery, 108, 1049–1054.PubMed

31.

Kim, K. C. C. K., Kim, Y. J., Sohn, D. W., & Kim, K. B. (2007). Long-term results of the Cox-Maze III procedure for persistent atrial fibrillation associated with rheumatic mitral valve disease: 10-year experience. European Journal of Cardio-thoracic Surgery, 31, 261–266.PubMedCrossRef

32.

Ishii, Y. S. R., Gaynor, S. L., Yamada, K., Fu, A. S., Boineau, J. P., Damiano, R. J., Jr. (2005). Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation. Circulation, 111, 2881–2888.PubMedCrossRef

33.

34.

Isobe F., & Kawashima Y. (1998). The outcome and indications of the Cox maze III procedure for chronic atrial fibrillation with mitral valve disease. Journal of Thoracic and Cardiovascular Surgery, 116, 220–227.PubMedCrossRef

35.

Marui, A. N. T., Tambara, K., Saji, Y., Shimamoto, T., Nishioka, M., Ikeda, T., et al. (2006). A novel atrial volume reduction technique to enhance the Cox maze procedure: Initial results. Journal of Thoracic and Cardiovascular Surgery, 132, 1047–1053.PubMedCrossRef

36.

Kosakai, Y. (2000). Treatment of atrial fibrillation using the Maze procedure: The Japanese experience. Seminars in Thoracic and Cardiovascular Surgery, 12, 44–52.PubMed

Titel: Atrial fibrillation surgery for patients with rheumatic valve disease
verfasst von: Yosuke Ishii
Takashi Nitta
Publikationsdatum: 01.12.2007
Verlag: Springer US
Erschienen in: Journal of Interventional Cardiac Electrophysiology / Ausgabe 3/2007
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI: https://doi.org/10.1007/s10840-007-9179-9

Neu im Fachgebiet Kardiologie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Atrial fibrillation surgery for patients with rheumatic valve disease

Abstract

Neu im Fachgebiet Kardiologie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

Update Kardiologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2007

Atrial fibrillation in patients with coronary disease

The Cox-Maze procedure: History, results, and predictors for failure

Surgical ablation devices for atrial fibrillation

Curing atrial fibrillation: Two decades of progress

Atrial fibrillation surgery in nonrheumatic mitral valve disease

Atrial arrhythmia surgery in congenital heart disease

Neu im Fachgebiet Kardiologie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

Update Kardiologie